Clinical Practice: Diagnosis and Evaluation of Dyspepsia

摘要: The main issue regarding the approach to patient with uninvestigated dyspepsia is whether symptoms are result of an important clinical illness, which then determines appropriate management strategy for treatment symptoms. An initial trial empiric antisecretory drugs recommended those without Helicobacter pylori infection and no alarm symptoms, whereas H. eradication active infection. Treatment expectations infections should theoretically be similar other common infectious diseases. In most regions, clarithromycin resistance has undermined traditional triple therapy so that it longer a suitable choice as therapy. Four drug therapies, such sequential, concomitant, bismuth-quadruple generally still acceptable choices therapies. Posteradication testing highly provide early identification otherwise unrecognized increasing antimicrobial resistance. However, despite ability successfully cure infections, symptomatic response can expected in only minority not associated ulcers (so called nonulcer dyspepsia). Overall, from patients stand point, relief often difficult achieve physicians must rely on reassurance along individualized care.